Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Visconti, MR; Langston, AL; Alonso, N; Goodman, K; Selby, PL; Fraser, WD; Ralston, SH.
Mutations of SQSTM1 are associated with severity and clinical outcome in paget disease of bone.
J Bone Miner Res. 2010; 25(11): 2368-73. Doi: 10.1002/jbmr.132
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Alonso Lopez Nerea
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Paget disease of bone (PDB) is a common disorder characterized by increased bone turnover at one of more sites throughout the skeleton. Genetic factors play an important role in the pathogenesis of PDB, and the most important predisposing gene is SQSTM1, which is mutated in about 10% of patients. Here we investigated the relationship between SQSTM1 mutation status, disease severity, and clinical outcome in 737 patients who took part in a randomized study of two different management strategies for the disease. Mutations of SQSTM1 were detected in 80 of 737 (10.9%) patients. Mutation carriers had an earlier age at diagnosis (59.4 ± 11.5 versus 65.0 ± 10.4 years, p < .0001) and a greater number of affected bones (3.2 ± 1.2 versus 2.1 ± 1.2, p < .001) and more commonly required orthopedic surgery (26.2% versus 16.1%, p = .024) and bisphosphonate therapy (86.3% versus 75.2%, p = .01) than those without mutations. Quality of life, as assessed by the short-form-36 (SF36) physical summary score, was significantly reduced in carriers (34.0 ± 11.3 versus 37.1 ± 11.4, p = .036). During the study, fractures were more common in carriers (12.5% versus 5.3%, p = .011), although most of these occurred in unaffected bone. This study demonstrates that SQSTM1 mutations are strongly associated with disease severity and complications of PDB. Genetic testing for SQSTM1 mutations may be of value in identifying individuals at risk of developing severe disease, but further studies will be required to determine if a program of genetic testing and early intervention in these individuals would be cost-effective or be of benefit in preventing these complications.
Find related publications in this database (using NLM MeSH Indexing)
Adaptor Proteins, Signal Transducing - genetics
Female - administration & dosage
Genetic Predisposition to Disease - administration & dosage
Humans - administration & dosage
Male - administration & dosage
Middle Aged - administration & dosage
Mutation - genetics
Osteitis Deformans - drug therapy, genetics, pathology
Sequestosome-1 Protein - administration & dosage
Severity of Illness Index - administration & dosage
Treatment Outcome - administration & dosage

Find related publications in this database (Keywords)
PAGETS DISEASE
GENETIC
SQSTM1
© Med Uni GrazImprint